Rare disease

Myelodysplastic syndrome

53 clinical trials

Quick filters

Clinical trials for Myelodysplastic syndrome

53 trials across Europe

See all trials →

Quick filters

53 Clinical trials

Myelofibrosis+3

Recruiting

Registered drugNo placebo

Study of RVU120 treatment in patients with myelodysplastic syndrome, solid tumors, or acute myeloid leukemia who benefited from previous RVU120 therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Ruxolitinib
Sponsor:Ryvu Therapeutics S.A.

Contact Research Centre

Anaemia+1

Recruiting

Registered drugNo placebo

A Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Elritercept
Sponsor:Takeda Development Center Americas Inc.

Contact Research Centre

Acute myeloid leukaemia refractory+2

Recruiting

InvestigationalNo placebo

Phase 1/2 Study of LB-208 in Adults with Relapsed or Refractory Acute Myeloid Leukaemia and High‑Risk Myelodysplastic Syndrome

InvestigationalNo placebo

Spain

Participants:18–64 years · 65+ years
Sponsor:Aop Orphan Pharmaceuticals GmbH

Contact Research Centre

Acute lymphocytic leukaemia recurrent+5

Recruiting

InvestigationalNo placebo

A study testing AZD3632 alone or with other anticancer drugs in adults with acute leukemia or myelodysplastic syndromes with HOX gene overexpression

InvestigationalNo placebo

Denmark

Participants:18–64 years · 65+ years
Substances:AZD3632
Sponsor:AstraZeneca AB

Contact Research Centre

Acute myeloid leukaemia+3

Recruiting

Registered drugNo placebo

Study comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Busulfan
Sponsor:Medizinische Hochschule Hannover

Contact Research Centre

Myelodysplastic syndrome

Recruiting

InvestigationalNo placebo

Study of momelotinib tablets in patients with anemia caused by low-risk myelodysplastic syndrome

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Momelotinib Dihydrochloride Monohydrate
Sponsor:Glaxosmithkline Research & Development Limited

Contact Research Centre

See all trials →

Myelodysplastic syndrome

Clinical trials for Myelodysplastic syndrome

Myelofibrosis+3

Study of RVU120 treatment in patients with myelodysplastic syndrome, solid tumors, or acute myeloid leukemia who benefited from previous RVU120 therapy

Anaemia+1

A Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions

Acute myeloid leukaemia refractory+2

Phase 1/2 Study of LB-208 in Adults with Relapsed or Refractory Acute Myeloid Leukaemia and High‑Risk Myelodysplastic Syndrome

Acute lymphocytic leukaemia recurrent+5

A study testing AZD3632 alone or with other anticancer drugs in adults with acute leukemia or myelodysplastic syndromes with HOX gene overexpression

Acute myeloid leukaemia+3

Study comparing standard and reduced intensity treatment in patients with acute myeloid leukemia or chronic lymphocytic leukemia who have no detectable disease after initial therapy

Myelodysplastic syndrome

Study of momelotinib tablets in patients with anemia caused by low-risk myelodysplastic syndrome

Filter the trials

Prefer not to search? Our Concierge searches the trials for you.